The startup, which offers remote assessments for conditions like ADHD and dyslexia, emerged from stealth Friday with a total of $4.2 million in funding.
Also: Pear Therapeutics reported $2.7 million in revenue for its first quarter compared with $1.3 million in Q4 2021.
On the heels of a $9.2 million Series A, Mahmee CEO and cofounder Melissa Hanna discusses the fragmented maternal healthcare experience in the U.S.
